Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001764013-24-000184
Filing Date
2024-11-07
Accepted
2024-11-07 06:49:49
Documents
59
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q imvt-20240930.htm   iXBRL 10-Q 1250283
2 EX-10.1 exhibit101-2024930q2.htm EX-10.1 70763
3 EX-31.1 exhibit311-2024930q2.htm EX-31.1 9758
4 EX-31.2 exhibit312-2024930q2.htm EX-31.2 9755
5 EX-32.1 exhibit321-2024930q2.htm EX-32.1 4465
6 EX-32.2 exhibit322-2024930q2.htm EX-32.2 4486
12 GRAPHIC imvt-20240930_g1.jpg GRAPHIC 146609
13 GRAPHIC imvt-20240930_g2.jpg GRAPHIC 155502
  Complete submission text file 0001764013-24-000184.txt   5580761

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imvt-20240930.xsd EX-101.SCH 26780
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imvt-20240930_cal.xml EX-101.CAL 38604
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imvt-20240930_def.xml EX-101.DEF 152319
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imvt-20240930_lab.xml EX-101.LAB 450065
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imvt-20240930_pre.xml EX-101.PRE 308184
61 EXTRACTED XBRL INSTANCE DOCUMENT imvt-20240930_htm.xml XML 367765
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

EIN.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-38906 | Film No.: 241433044
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)